153 related articles for article (PubMed ID: 37077947)
1. Establishment and characterization of a multi-drug resistant cell line for canine mammary tumors.
Zhou C; Lin Z; Li X; Zhang D; Song P
Front Vet Sci; 2023; 10():1129756. PubMed ID: 37077947
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of a HER2-enriched canine mammary cancerous myoepithelial cell line.
Chen A; Ye S; Zheng J; Li J; Chen Z; Zhang Y; Li S
BMC Vet Res; 2023 Jan; 19(1):22. PubMed ID: 36717813
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of a new triple-negative canine mammary cancer cell line.
Zhang H; Pei S; Zhou B; Wang H; Du H; Zhang D; Lin D
Tissue Cell; 2018 Oct; 54():10-19. PubMed ID: 30309498
[TBL] [Abstract][Full Text] [Related]
4. Characterization of protein marker expression, tumorigenicity, and doxorubicin chemoresistance in two new canine mammary tumor cell lines.
Hsiao YL; Hsieh TZ; Liou CJ; Cheng YH; Lin CT; Chang CY; Lai YS
BMC Vet Res; 2014 Sep; 10():229. PubMed ID: 25267010
[TBL] [Abstract][Full Text] [Related]
5. Immortalization and characterization of a new canine mammary tumour cell line FR37-CMT.
Raposo LR; Roma-Rodrigues C; Faísca P; Alves M; Henriques J; Carvalheiro MC; Corvo ML; Baptista PV; Pombeiro AJ; Fernandes AR
Vet Comp Oncol; 2017 Sep; 15(3):952-967. PubMed ID: 27140424
[TBL] [Abstract][Full Text] [Related]
6. A Novel Canine Mammary Cancer Cell Line: Preliminary Identification and Utilization for Drug Screening Studies.
Li R; Wu H; Sun Y; Zhu J; Tang J; Kuang Y; Li G
Front Vet Sci; 2021; 8():665906. PubMed ID: 34124226
[TBL] [Abstract][Full Text] [Related]
7. Establishment and transcriptome characterization of tamoxifen-resistant canine mammary gland tumor cells.
Xu E; Guan T; Hu M; Tong D; Ge R; Liu Y
Res Vet Sci; 2022 Jul; 145():135-146. PubMed ID: 35193047
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a New Cell Line of Canine Mammary Tumor CMT-1026.
Mei C; Xin L; Liu Y; Lin J; Xian H; Zhang X; Hu W; Xia Z; Wang H; Lyu Y
Front Vet Sci; 2021; 8():744032. PubMed ID: 34712723
[TBL] [Abstract][Full Text] [Related]
9. Establishment of 5-Fluorouracil-resistant canine mammary tumor cell line.
Zhou B; Zhang D; Pei SM; Zhang H; Du HC; Jin YP; Lin DG
Pol J Vet Sci; 2017 Mar; 20(1):103-110. PubMed ID: 28525328
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive Evaluation of Multidrug Resistance via Imaging of ABCG2/BCRP Multidrug Transporter in Lung Cancer Xenograft Models.
Li C; Yang Q; Chen Z; Qiu Y; Du Y; Wang R; He Q; Yang J; Zhen H; Kang L
Mol Pharm; 2022 Oct; 19(10):3521-3529. PubMed ID: 35427142
[TBL] [Abstract][Full Text] [Related]
11. LncRNA Expression Profiles in Canine Mammary Tumors Identify lnc34977 as a Promoter of Proliferation, Migration and Invasion of Canine Mammary Tumor Cells.
Lu B; Wu J; Chen H; Li S; Jia K
Vet Sci; 2022 Feb; 9(2):. PubMed ID: 35202335
[TBL] [Abstract][Full Text] [Related]
12. Expression and role of PGP, BCRP, MRP1 and MRP3 in multidrug resistance of canine mammary cancer cells.
Pawłowski KM; Mucha J; Majchrzak K; Motyl T; Król M
BMC Vet Res; 2013 Jun; 9():119. PubMed ID: 23773525
[TBL] [Abstract][Full Text] [Related]
13. ABCG2/BCRP gene expression is related to epithelial-mesenchymal transition inducer genes in a papillary thyroid carcinoma cell line (TPC-1).
Mato E; González C; Moral A; Pérez JI; Bell O; Lerma E; de Leiva A
J Mol Endocrinol; 2014 Jun; 52(3):289-300. PubMed ID: 24643400
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance in breast cancer cells during epithelial-mesenchymal transition is modulated by breast cancer resistant protein.
Chen WJ; Wang H; Tang Y; Liu CL; Li HL; Li WT
Chin J Cancer; 2010 Feb; 29(2):151-7. PubMed ID: 20109342
[TBL] [Abstract][Full Text] [Related]
15. Effect of Melatonin in Epithelial Mesenchymal Transition Markers and Invasive Properties of Breast Cancer Stem Cells of Canine and Human Cell Lines.
Gonçalves Ndo N; Colombo J; Lopes JR; Gelaleti GB; Moschetta MG; Sonehara NM; Hellmén E; Zanon Cde F; Oliani SM; Zuccari DA
PLoS One; 2016; 11(3):e0150407. PubMed ID: 26934679
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Validation of the Hippo Pathway as a Pharmacological Target for Canine Mammary Gland Tumors.
Guillemette S; Rico C; Godin P; Boerboom D; Paquet M
J Mammary Gland Biol Neoplasia; 2017 Sep; 22(3):203-214. PubMed ID: 28822004
[TBL] [Abstract][Full Text] [Related]
17. Systematic expression analysis of genes related to multidrug-resistance in isogenic docetaxel- and adriamycin-resistant breast cancer cell lines.
Li WJ; Zhong SL; Wu YJ; Xu WD; Xu JJ; Tang JH; Zhao JH
Mol Biol Rep; 2013 Nov; 40(11):6143-50. PubMed ID: 24078162
[TBL] [Abstract][Full Text] [Related]
18. Ixabepilone, a novel microtubule-targeting agent for breast cancer, is a substrate for P-glycoprotein (P-gp/MDR1/ABCB1) but not breast cancer resistance protein (BCRP/ABCG2).
Shen H; Lee FY; Gan J
J Pharmacol Exp Ther; 2011 May; 337(2):423-32. PubMed ID: 21262849
[TBL] [Abstract][Full Text] [Related]
19. Multi-drug resistance in a canine lymphoid cell line due to increased P-glycoprotein expression, a potential model for drug-resistant canine lymphoma.
Zandvliet M; Teske E; Schrickx JA
Toxicol In Vitro; 2014 Dec; 28(8):1498-506. PubMed ID: 24975508
[TBL] [Abstract][Full Text] [Related]
20. CA 15-3 cell lines and tissue expression in canine mammary cancer and the correlation between serum levels and tumour histological grade.
Manuali E; De Giuseppe A; Feliziani F; Forti K; Casciari C; Marchesi MC; Pacifico E; Pawłowski KM; Majchrzak K; Król M
BMC Vet Res; 2012 Jun; 8():86. PubMed ID: 22726603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
